{'fraction_non_alphanumeric': 0.02527075812274368, 'fraction_numerical': 0.007220216606498195, 'mean_word_length': 5.166666666666667, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Interleukin-2 and its use in hemo-proliferative disorders].

Interleukin 2 (IL-2) is a cytokine which activates cytotoxic cells and stimulates T suppressor cells and may play a role in the treatment of neoplastic disorders. The majority of clinical trials were performed in renal carcinoma and melanoma. Recent studies showed that IL-2 may also play a role in the treatment of hemoproliferative disorders, but its effectiveness was shown mostly in eradication of minimal residual disease after aggressive chemotherapy and/or bone marrow transplantation.